Ionis Pharmaceuticals Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: IONS
Share price (3/17/26): $72.33
Market cap (3/17/26): $11.9 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 83 pages Agreement and Plan of Merger Among Akcea Therapeutics, Inc., a Delaware Corporation; Ionis Pharmaceuticals, Inc., a Delaware Corporation; and Avalanche Merger Sub, Inc., a Delaware Corporation Dated as of August 30, 2020

from SC TO-C 83 pages Agreement and Plan of Merger Among Akcea Therapeutics, Inc., a Delaware Corporation; Ionis Pharmaceuticals, Inc., a Delaware Corporation; and Avalanche Merger Sub, Inc., a Delaware Corporation Dated as of August 30, 2020

from 8-K ~20 pages Clinical Supply Agreement

from 8-K ~50 pages Development and License Agreement

from 8-K >50 pages Collaboration Agreement

from 8-K ~20 pages Registration Rights and Standstill Agreement

from 8-K ~20 pages Plan of reorganization, merger, acquisition or similar

from 8-K ~20 pages Securities Purchase Agreement